Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy

• Hlavní autoři: Yang Tian (Autor), Zhen Shi (Autor), Jiahao Cai (Autor), Chi Hou (Autor), Xiuying Wang (Autor), Haixia Zhu (Autor), Binwei Peng (Autor), Kaili Shi (Autor), Xiaojing Li (Autor), Sitang Gong (Autor), Wen-Xiong Chen (Autor)
• Médium: Kniha
• Vydáno: BMC, 2023-10-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Abstract Introduction Self-limited infantile epilepsy (SeLIE) is a benign epilepsy. Previous studies have shown that monotherapy with most antiseizure medications can effectively relieve seizures in patients with SeLIE, but the efficacy of levetiracetam has not been investigated. Objective This stud...